Guardant Health, Inc. (NASDAQ:GH) Receives $56.27 Average Target Price from Analysts
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have been assigned an average rating of “Moderate Buy” from the thirteen research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. The average […]